Review



vx 659  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress vx 659
    Vx 659, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vx 659/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    vx 659 - by Bioz Stars, 2026-02
    94/100 stars

    Images



    Similar Products

    94
    MedChemExpress vx 659
    Vx 659, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vx 659/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    vx 659 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    90
    Vertex Pharmaceuticals vx-659
    Vx 659, supplied by Vertex Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vx-659/product/Vertex Pharmaceuticals
    Average 90 stars, based on 1 article reviews
    vx-659 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Vertex Pharmaceuticals compound-216- bamocaftor, or vx-659
    Compound 216 Bamocaftor, Or Vx 659, supplied by Vertex Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/compound-216- bamocaftor, or vx-659/product/Vertex Pharmaceuticals
    Average 90 stars, based on 1 article reviews
    compound-216- bamocaftor, or vx-659 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Selleck Chemicals cftr corrector cocktail vx-659
    Cftr Corrector Cocktail Vx 659, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cftr corrector cocktail vx-659/product/Selleck Chemicals
    Average 90 stars, based on 1 article reviews
    cftr corrector cocktail vx-659 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Selleck Chemicals vx-659 (1 µm)
    CFTR correctors caused a decrease in P. aeruginosa burden when co-cultured with HBE. ( A , B ) Primary CF HBE cultures (F508del/F508del) were treated with 58 µg/mL tobramycin 3 h after P. aeruginosa PAO1 infection (+ Pa ) or mock infection with media alone (− Pa ). Infection/mock infection was for 24 h. Correctors (Corr) VX-661 (10 µM) and <t>VX-659</t> (1 µM) or VX-445 (3 µM) were added basolaterally at the time of infection. ( A ) Epithelial cultures remained intact 24 h after P. aeruginosa infection, as measured by resistance in Ussing chambers (4 donors, n = 2–4 per donor). ( B ) P. aeruginosa burden from apical washings from vehicle or corrector-rescued CF HBE cultures. P. aeruginosa burden was decreased in the presence of CFTR correctors. Data points represent the average for each HBE culture donor (4 donors, n = 5–6 per donor). ( C , D ) Direct treatment (no HBE) of P. aeruginosa with CFTR modulators and tobramycin. ( C ) P. aeruginosa growth in cell culture medium in the presence of vehicle (DMSO) or CFTR modulators individually and in combination. ( D ) Minimum inhibitory concentration (MIC) of P. aeruginosa to tobramycin in the absence or presence of CFTR modulators or vehicle control (DMSO). Statistical significance was determined by one-way ANOVA with Dunnet’s multiple comparison, * p < 0.05, ns = not significant.
    Vx 659 (1 µm), supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vx-659 (1 µm)/product/Selleck Chemicals
    Average 90 stars, based on 1 article reviews
    vx-659 (1 µm) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Vertex Pharmaceuticals small molecule correctors cftr vx-659
    CFTR correctors caused a decrease in P. aeruginosa burden when co-cultured with HBE. ( A , B ) Primary CF HBE cultures (F508del/F508del) were treated with 58 µg/mL tobramycin 3 h after P. aeruginosa PAO1 infection (+ Pa ) or mock infection with media alone (− Pa ). Infection/mock infection was for 24 h. Correctors (Corr) VX-661 (10 µM) and <t>VX-659</t> (1 µM) or VX-445 (3 µM) were added basolaterally at the time of infection. ( A ) Epithelial cultures remained intact 24 h after P. aeruginosa infection, as measured by resistance in Ussing chambers (4 donors, n = 2–4 per donor). ( B ) P. aeruginosa burden from apical washings from vehicle or corrector-rescued CF HBE cultures. P. aeruginosa burden was decreased in the presence of CFTR correctors. Data points represent the average for each HBE culture donor (4 donors, n = 5–6 per donor). ( C , D ) Direct treatment (no HBE) of P. aeruginosa with CFTR modulators and tobramycin. ( C ) P. aeruginosa growth in cell culture medium in the presence of vehicle (DMSO) or CFTR modulators individually and in combination. ( D ) Minimum inhibitory concentration (MIC) of P. aeruginosa to tobramycin in the absence or presence of CFTR modulators or vehicle control (DMSO). Statistical significance was determined by one-way ANOVA with Dunnet’s multiple comparison, * p < 0.05, ns = not significant.
    Small Molecule Correctors Cftr Vx 659, supplied by Vertex Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/small molecule correctors cftr vx-659/product/Vertex Pharmaceuticals
    Average 90 stars, based on 1 article reviews
    small molecule correctors cftr vx-659 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Vertex Pharmaceuticals vx-659 bamocaftor
    CFTR modulators other than those in current clinical use.
    Vx 659 Bamocaftor, supplied by Vertex Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vx-659 bamocaftor/product/Vertex Pharmaceuticals
    Average 90 stars, based on 1 article reviews
    vx-659 bamocaftor - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    CFTR correctors caused a decrease in P. aeruginosa burden when co-cultured with HBE. ( A , B ) Primary CF HBE cultures (F508del/F508del) were treated with 58 µg/mL tobramycin 3 h after P. aeruginosa PAO1 infection (+ Pa ) or mock infection with media alone (− Pa ). Infection/mock infection was for 24 h. Correctors (Corr) VX-661 (10 µM) and VX-659 (1 µM) or VX-445 (3 µM) were added basolaterally at the time of infection. ( A ) Epithelial cultures remained intact 24 h after P. aeruginosa infection, as measured by resistance in Ussing chambers (4 donors, n = 2–4 per donor). ( B ) P. aeruginosa burden from apical washings from vehicle or corrector-rescued CF HBE cultures. P. aeruginosa burden was decreased in the presence of CFTR correctors. Data points represent the average for each HBE culture donor (4 donors, n = 5–6 per donor). ( C , D ) Direct treatment (no HBE) of P. aeruginosa with CFTR modulators and tobramycin. ( C ) P. aeruginosa growth in cell culture medium in the presence of vehicle (DMSO) or CFTR modulators individually and in combination. ( D ) Minimum inhibitory concentration (MIC) of P. aeruginosa to tobramycin in the absence or presence of CFTR modulators or vehicle control (DMSO). Statistical significance was determined by one-way ANOVA with Dunnet’s multiple comparison, * p < 0.05, ns = not significant.

    Journal: Cells

    Article Title: A Novel Co-Culture Model Reveals Enhanced CFTR Rescue in Primary Cystic Fibrosis Airway Epithelial Cultures with Persistent Pseudomonas aeruginosa Infection

    doi: 10.3390/cells12222618

    Figure Lengend Snippet: CFTR correctors caused a decrease in P. aeruginosa burden when co-cultured with HBE. ( A , B ) Primary CF HBE cultures (F508del/F508del) were treated with 58 µg/mL tobramycin 3 h after P. aeruginosa PAO1 infection (+ Pa ) or mock infection with media alone (− Pa ). Infection/mock infection was for 24 h. Correctors (Corr) VX-661 (10 µM) and VX-659 (1 µM) or VX-445 (3 µM) were added basolaterally at the time of infection. ( A ) Epithelial cultures remained intact 24 h after P. aeruginosa infection, as measured by resistance in Ussing chambers (4 donors, n = 2–4 per donor). ( B ) P. aeruginosa burden from apical washings from vehicle or corrector-rescued CF HBE cultures. P. aeruginosa burden was decreased in the presence of CFTR correctors. Data points represent the average for each HBE culture donor (4 donors, n = 5–6 per donor). ( C , D ) Direct treatment (no HBE) of P. aeruginosa with CFTR modulators and tobramycin. ( C ) P. aeruginosa growth in cell culture medium in the presence of vehicle (DMSO) or CFTR modulators individually and in combination. ( D ) Minimum inhibitory concentration (MIC) of P. aeruginosa to tobramycin in the absence or presence of CFTR modulators or vehicle control (DMSO). Statistical significance was determined by one-way ANOVA with Dunnet’s multiple comparison, * p < 0.05, ns = not significant.

    Article Snippet: A CFTR corrector cocktail containing 2 correctors, either VX-659 (1 µM) or VX-445 (3 µM) plus VX-661 (10 µM) (Selleck Chemicals LLC, Houston, TX, USA), was applied to HBE cultures on the basolateral side chronically for 24 h. Potentiator VX-770 (1 µM) was added to the apical side of cultures for 30 min during Ussing chamber measurement or 30 min prior to lysing for Western blot or mRNA analysis, to mimic acute VX-770 treatment.

    Techniques: Cell Culture, Infection, Concentration Assay, Comparison

    CFTR modulators other than those in current clinical use.

    Journal: International Journal of Molecular Sciences

    Article Title: New Therapies to Correct the Cystic Fibrosis Basic Defect

    doi: 10.3390/ijms22126193

    Figure Lengend Snippet: CFTR modulators other than those in current clinical use.

    Article Snippet: VX-659 bamocaftor , Vertex Pharmaceuticals , Corrector , NCT03447249.

    Techniques: